Cresset Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,919
| Closed | -$977K | – | 1699 |
|
|
2024
Q3 | $977K | Buy |
2,919
+159
| +6% | +$53.2K | ﹤0.01% | 1149 |
|
|
2024
Q2 | $754K | Sell |
2,760
-659
| -19% | -$180K | ﹤0.01% | 1193 |
|
|
2024
Q1 | $1.18M | Buy |
3,419
+642
| +23% | +$222K | 0.01% | 886 |
|
|
2023
Q4 | $897K | Buy |
2,777
+716
| +35% | +$231K | 0.01% | 922 |
|
|
2023
Q3 | $739K | Buy |
2,061
+534
| +35% | +$191K | ﹤0.01% | 955 |
|
|
2023
Q2 | $579K | Buy |
+1,527
| New | +$579K | ﹤0.01% | 1069 |
|
|
2021
Q4 | – | Sell |
-591
| Closed | -$440K | – | 1139 |
|
|
2021
Q3 | $440K | Buy |
591
+91
| +18% | +$67.8K | 0.01% | 684 |
|
|
2021
Q2 | $323K | Buy |
500
+40
| +9% | +$25.8K | ﹤0.01% | 734 |
|
|
2021
Q1 | $263K | Buy |
460
+43
| +10% | +$24.6K | ﹤0.01% | 738 |
|
|
2020
Q4 | $243K | Buy |
+417
| New | +$243K | ﹤0.01% | 632 |
|
|
2019
Q2 | – | Sell |
-256
| Closed | -$78K | – | 616 |
|
|
2019
Q1 | $78K | Buy |
256
+66
| +35% | +$20.1K | ﹤0.01% | 633 |
|
|
2018
Q4 | $44K | Buy |
+190
| New | +$44K | ﹤0.01% | 513 |
|